Lifeboat Foundation

Worrying can lead to high anxiety, which can trigger physical illness. Learn more from WebMD about how excessive worrying can affect your health — and how to manage it.

Baby, you’re a firework.

Eliminating mistakes about eliminative materialism.

Shared with Dropbox.

Brain inspired machine intelligence.

Shared with Dropbox.

Red Teaming GPT-4V

Are GPT-4V safe against uni/multi-modal jailbreak attacks?

Join the discussion on this paper page.

Get Free TESLA Milestone Tables My website: https://www.TeslaInvestor.comCheck out 15+ modules of resources for the $TSLA InvestorJoin this channel or Patreo…

Two populations will appear at the same time, carpeting an area from southern Wisconsin to the Carolinas.

Gene therapy may be the best hope for curing retinitis pigmentosa (RP), an inherited condition that usually leads to severe vision loss and blinds 1.5 million people worldwide.

But there’s a huge obstacle: RP can be caused by mutations in over 80 different genes. To treat most RP patients with gene therapy, researchers would have to create a therapy for each gene—a nearly impractical task using current gene therapy strategies.

A more universal treatment may be forthcoming. Using CRISPR-based genome engineering, scientists at Columbia University Vagelos College of Physicians and Surgeons are designing a gene therapy with the potential to treat RP patients regardless of the underlying genetic defect.

Weill Cornell Medicine scientists have developed an innovative human neuron model that robustly simulates the spread of tau protein aggregates in the brain—a process that drives cognitive decline in Alzheimer’s disease and frontotemporal dementia. This new model has led to the identification of novel therapeutic targets that could potentially block tau spread.